These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29285810)

  • 1. Von Willebrand factor revisited.
    Yasar SJ; Abdullah O; Fay W; Balla S
    J Interv Cardiol; 2018 Jun; 31(3):360-367. PubMed ID: 29285810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of Mini-Invasive Transcatheter Aortic Valve Replacement?
    Vincent F; Rauch A; Spillemaeker H; Vincentelli A; Paris C; Rosa M; Dupont A; Delhaye C; Verdier B; Robin E; Lenting PJ; Susen S; Van Belle E
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1775-1778. PubMed ID: 30190067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement.
    Spangenberg T; Budde U; Schewel D; Frerker C; Thielsen T; Kuck KH; Schäfer U
    JACC Cardiovasc Interv; 2015 Apr; 8(5):692-700. PubMed ID: 25946442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
    Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
    JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.
    Van Belle E; Rauch A; Vincent F; Robin E; Kibler M; Labreuche J; Jeanpierre E; Levade M; Hurt C; Rousse N; Dally JB; Debry N; Dallongeville J; Vincentelli A; Delhaye C; Auffray JL; Juthier F; Schurtz G; Lemesle G; Caspar T; Morel O; Dumonteil N; Duhamel A; Paris C; Dupont-Prado A; Legendre P; Mouquet F; Marchant B; Hermoire S; Corseaux D; Moussa K; Manchuelle A; Bauchart JJ; Loobuyck V; Caron C; Zawadzki C; Leroy F; Bodart JC; Staels B; Goudemand J; Lenting PJ; Susen S
    N Engl J Med; 2016 Jul; 375(4):335-44. PubMed ID: 27464202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation.
    Pawlitschek F; Keyl C; Zieger B; Budde U; Beyersdorf F; Neumann FJ; Stratz C; Nührenberg TG; Trenk D
    Thromb Haemost; 2018 Jan; 118(1):103-111. PubMed ID: 29304530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic Regurgitation after TAVR: From Bad to Worse.
    Hiltrop N; Adriaenssens T; Herijgers P; Dubois C
    J Heart Valve Dis; 2016 Mar; 25(2):182-184. PubMed ID: 27989062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
    Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
    J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
    Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
    Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
    Van Belle E; Rauch A; Vincentelli A; Jeanpierre E; Legendre P; Juthier F; Hurt C; Banfi C; Rousse N; Godier A; Caron C; Elkalioubie A; Corseaux D; Dupont A; Zawadzki C; Delhaye C; Mouquet F; Schurtz G; Deplanque D; Chinetti G; Staels B; Goudemand J; Jude B; Lenting PJ; Susen S
    Circ Res; 2015 Mar; 116(7):1193-201. PubMed ID: 25670067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients.
    Schäfer U; Deuschl F; Schofer N; Frerker C; Schmidt T; Kuck KH; Kreidel F; Schirmer J; Mizote I; Reichenspurner H; Blankenberg S; Treede H; Conradi L
    Int J Cardiol; 2017 Apr; 232():247-254. PubMed ID: 28118931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prosthesis sizing for transcatheter aortic valve implantation--comparison of three dimensional transesophageal echocardiography with multislice computed tomography.
    Husser O; Holzamer A; Resch M; Endemann DH; Nunez J; Bodi V; Schmid C; Riegger GA; Gössmann H; Hamer O; Stroszczynski C; Luchner A; Hilker M; Hengstenberg C
    Int J Cardiol; 2013 Oct; 168(4):3431-8. PubMed ID: 23688431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time three-dimensional transesophageal echocardiography adds value to transcatheter aortic valve implantation.
    Smith LA; Dworakowski R; Bhan A; Delithanasis I; Hancock J; Maccarthy PA; Wendler O; Thomas MR; Monaghan MJ
    J Am Soc Echocardiogr; 2013 Apr; 26(4):359-69. PubMed ID: 23484436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired von Willebrand syndrome in aortic stenosis.
    Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
    N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosis.
    Varghese SS; Hetu MF; Bowman M; Herr J; Al-Turki M; Jaff Z; James P; Malik P; Payne D; Johri AM
    Haemophilia; 2023 Sep; 29(5):1306-1312. PubMed ID: 37428626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-Procedural Hemodynamic Status Improves the Discriminatory Value of the Aortic Regurgitation Index in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Sinning JM; Stundl A; Pingel S; Weber M; Sedaghat A; Hammerstingl C; Vasa-Nicotera M; Mellert F; Schiller W; Kovac J; Welz A; Grube E; Werner N; Nickenig G
    JACC Cardiovasc Interv; 2016 Apr; 9(7):700-11. PubMed ID: 27056309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor and the aortic valve: Concepts that are important in the transcatheter aortic valve replacement era.
    Ibrahim H; Rondina MT; Kleiman NS
    Thromb Res; 2018 Oct; 170():20-27. PubMed ID: 30092557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.